journal
Journals Allergy, Asthma, and Clinical ...

Allergy, Asthma, and Clinical Immunology

https://read.qxmd.com/read/38311747/real-world-outcomes-of-mepolizumab-for-the-treatment-of-severe-eosinophilic-asthma-in-canada-an-observational-study
#21
JOURNAL ARTICLE
Kenneth R Chapman, Kathryn Cogger, Erin Arthurs, Callahan LaForty, Shane Golden, Bradley Millson, Koyo Usuba, Christopher Licskai
BACKGROUND: Mepolizumab, the first widely available anti-interleukin 5 biologic, targets eosinophilic inflammation and has been shown in clinical trials to reduce exacerbations, oral corticosteroid dependence, and healthcare utilization in patients with severe asthma. The impact of mepolizumab in a real-world, publicly funded healthcare setting is unknown. The objective of this study was to describe the demographics and clinical characteristics of real-world patients receiving mepolizumab, and to compare asthma-related outcomes and associated asthma-related costs before and during mepolizumab use...
February 4, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38310323/the-prevalence-of-obstructive-sleep-apnea-in-japanese-asthma-patients
#22
JOURNAL ARTICLE
Mina Yasuda, Kazunori Tobino, Norihiro Harada, Ryunosuke Ooi, Takuto Sueyasu, Saori Nishizawa, Miyuki Munechika, Kohei Yoshimine, Yuki Ko, Yuki Yoshimatsu, Kosuke Tsuruno, Hiromi Ide, Kazuhisa Takahashi
BACKGROUND: Obstructive sleep apnea (OSA) occurs more commonly in asthma patients than in the general population because these conditions share some comorbidities. In Japan, the prevalence of OSA in the general population is reported to be approximately 20%; however, few reports have described the prevalence of OSA in asthma patients. Furthermore, the characteristics of Japanese patients with OSA and asthma are not clear. METHODS: Adult asthma patients were recruited from the outpatient departments of our institution between August 31, 2017, and March 31, 2019...
February 3, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38310247/delayed-presentation-of-food-protein-induced-enterocolitis-syndrome-fpies-to-okra-in-a-toddler
#23
JOURNAL ARTICLE
Hunter Hall, Sara Anvari, Fallon Schultz, Olubukola Ojuola, Nicholas L Rider
BACKGROUND: Food protein-induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE) -mediated food allergy predominantly observed in infants and characterized by the delayed onset of vomiting following ingestion of a trigger food. An increase in research and clinical consideration of FPIES has led to the discovery of unique deviations from the standard FPIES triggers and presentations. CASE PRESENTATION: A 34-month-old female patient with a history of consuming okra daily presented to medical attention after developing classic FPIES symptoms to okra beginning at 14-months of age...
February 3, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38308375/association-of-single-nucleotide-polymorphisms-in-the-f2rl1-gene-with-clinical-and-inflammatory-characteristics-of-patients-with-asthma
#24
JOURNAL ARTICLE
Nami Shrestha Palikhe, Qahir Haji, Emily Mack, Tristan Sinnatamby, Andrew J Sandford, Lisa Cameron, Harissios Vliagoftis
BACKGROUND: Proteinase-activated receptor 2 (PAR-2) is a G-protein coupled receptor associated with many inflammatory diseases, including asthma. We have shown an association between PAR-2 expression in peripheral blood monocytes and asthma severity as well as blood PAR-2 mRNA level and lung function. Since F2RL1 (the gene encoding PAR-2) polymorphisms affect PAR-2 expression, we hypothesize they may affect asthma severity. METHODS: We recruited 76 subjects with asthma of varying severity and collected clinical (FEV1 [% predicted], FEV1 /FVC, IgE) and immunological (PAR-2 mRNA, blood eosinophils) disease parameters...
February 2, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38254221/resource-utilization-and-cost-assessment-of-a-proactive-penicillin-allergy-de-labeling-program-for-low-risk-inpatients
#25
JOURNAL ARTICLE
Derek Lanoue, Adhora Mir, Carl van Walraven, Timothy Olynych, Caroline Nott, Derek R MacFadden
BACKGROUND: Resource utilization and costs can impede proactive assessment and de-labeling of penicillin allergy among inpatients. METHODS: Our pilot intervention was a proactive penicillin allergy de-labeling program for new inpatients with penicillin allergy. Patients deemed appropriate for a challenge with a low-risk penicillin allergy history were administered 250 mg amoxicillin and monitored for 1 h. We performed an explorative economic evaluation using various healthcare professional wages...
January 22, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38233962/inborn-errors-of-immunity-in-adulthood
#26
REVIEW
Joanne J F Wang, Arün Dhir, Kyla J Hildebrand, Stuart E Turvey, Robert Schellenberg, Luke Y C Chen, Persia Pourshahnazari, Catherine M Biggs
Inborn errors of immunity (IEIs) are a group of conditions whereby parts of the immune system are missing or dysfunctional. Once thought to primarily be a pediatric disorder, it is now estimated that more than 50% of worldwide incident IEI cases are accounted for by adults. Delayed diagnosis, late symptom onset, and IEI phenocopies can all lead to adult-onset recognition of IEIs. Lack of awareness regarding the diversity of IEI manifestations in adults contributes to diagnostic and treatment delays. Prompt referral to immunology is critical so that patients can receive a precise molecular diagnosis and targeted therapy when available...
January 17, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38221641/accelerometer-derived-sleep-metrics-in-mild-and-difficult-to-treat-asthma
#27
LETTER
Varun Sharma, Helen Clare Ricketts, Femke Steffensen, Anna Goodfellow, Duncan S Buchan, Douglas C Cowan
INTRODUCTION: Poor sleep health is associated with increased asthma morbidity and mortality. Accelerometers have been validated to assess sleep parameters though studies using this method in patients with asthma are sparse and none have compared mild to difficult-to-treat asthma populations. METHODS: We performed a retrospective analysis from two recent in-house trials comparing sleep metrics between patients with mild and difficult-to-treat asthma. Participants wore accelerometers for 24-hours/day for seven days...
January 14, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38221621/update-on-the-association-between-helicobacter-pylori-infection-and-asthma-in-terms-of-microbiota-and-immunity
#28
REVIEW
Mengmeng Liu, Yong Wang, Bing Du
H. pylori is a gram-negative bacterium that is usually acquired in childhood and can persistently colonize the gastric mucosa of humans, affecting approximately half of the world's population. In recent years, the prevalence of H. pylori infection has steadily reduced while the risk of allergic diseases has steadily climbed. As a result, epidemiological research indicates a strong negative association between the two. Moreover, numerous experimental studies have demonstrated that eradicating H. pylori increases the risk of allergic diseases...
January 14, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38218943/different-expression-levels-of-interleukin-36-in-asthma-phenotypes
#29
JOURNAL ARTICLE
Jinyan Li, Zhengda Wang, Hongna Dong, Yuqiu Hao, Peng Gao, Wei Li
Interleukin (IL)-36 family is closely associated with inflammation and consists of IL-36α, IL-36β, IL-36γ, and IL-36Ra. The role of IL-36 in the context of asthma and asthmatic phenotypes is not well characterized. We examined the sputum IL-36 levels in patients with different asthma phenotypes in order to unravel the mechanism of IL-36 in different asthma phenotypes. Our objective was to investigate the induced sputum IL-36α, IL-36β, IL-36γ, and IL-36Ra concentrations in patients with mild asthma, and to analyze the relationship of these markers with lung function and other cytokines in patients with different asthma phenotypes...
January 13, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38178177/pollen-food-allergy-syndrome-secondary-to-molds-and-raw-mushroom-cross-reactivity-a-case-report
#30
JOURNAL ARTICLE
Ryan Gauld, Graham Walter, Rongbo Zhu
BACKGROUND: Pollen food allergy syndrome (PFAS) is an immunoglobulin E (IgE) mediated reaction that causes oropharyngeal pruritus or angioedema due to homologous proteins present in the culprit food as well as a sensitizing aeroallergen. This cross-reactivity has been well established between pollen and fruits/vegetables. Given the evolutionary similarity between all fungi; cross-reactivity between spore forming microfungi and edible macrofungi have been suggested, however only a limited number of case reports have ever been published on this phenomenon...
January 4, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38167134/il-1%C3%AE-and-inos-can-drive-the-asthmatic-comorbidities-and-decrease-of-lung-function-in-perennial-allergic-rhinitis-children
#31
JOURNAL ARTICLE
Myung Woul Han, Song Hee Kim, Inbo Oh, Yang Ho Kim, Jiho Lee
BACKGROUND: Allergic asthma and rhinitis (AR) are closely linked, with a significant proportion of AR patients developing asthma. Identification of the early signs of comorbidity of AR and asthma can enable prompt treatment and prevent asthma progression. OBJECTIVES AND METHODS: This study investigated the role of interleukin-1β (IL-1β), a pro-inflammatory cytokine, and inducible nitric oxide synthase (iNOS) in the comorbidity of AR and asthma and lung function in Korean children with perennial AR (PAR)...
January 2, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38124188/13th-c1-inhibitor-deficiency-and-angioedema-workshop-2023-edited-by-r%C3%A3-bert-hohol-lectored-by-henriette-farkas-lilian-varga-cover-artwork-gergely-hossz%C3%A3%C2%BA
#32
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 20, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38115026/associations-between-ht-bmi-and-allergic-rhinitis-in-perimenopausal-women
#33
JOURNAL ARTICLE
Jingyi Liu, Tingting Ma, Xiaoxue Wang, Wenpei Bai, Xueyan Wang
BACKGROUND: Increasing evidence suggests that hormone therapy (HT) and obesity exert an influence on allergic rhinitis (AR). It is important to investigate the association and interactions between HT, BMI, and AR in perimenopausal women. METHODS: From May 2020 to March 2021, a cross-sectional survey was completed by patients who visited the Allergy Department and Gynecology Department of Shijitan Hospital. The patients completed a questionnaire and stratified analyses by BMI in tertiles were performed...
December 19, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38082409/patient-outcomes-associated-with-subcutaneous-c1inh-prophylaxis-for-hereditary-angioedema-a-retrospective-analysis
#34
JOURNAL ARTICLE
William Lumry, Timothy Craig, John Anderson, Marc Riedl, Henry Li, Raffi Tachdjian, Michael Manning, Paolo Bajcic, Frank Rodino, Sam Wang, Thomas R Sexton, Jonathan A Bernstein
BACKGROUND: Real-world data on subcutaneous C1INH (C1INH[SC]) usage and patient-level impacts on hereditary angioedema (HAE)-related outcomes and quality of life (QoL) are both lacking and challenging to generate using conventional study methodologies. Using a hybrid study design involving patient interviews supplemented by retrospective medical chart data review, we conducted a real-world assessment of the impact of C1INH(SC) prophylaxis on HAE attack patterns, QoL, and on-demand medication use...
December 11, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38066550/biologic-use-and-treatment-patterns-in-patients-with-chronic-rhinosinusitis-with-nasal-polyps-a-us-real-world-study
#35
JOURNAL ARTICLE
Jared Silver, Elizabeth Packnett, Julie Park, Arijita Deb
BACKGROUND: Several biologics are now approved in the US as add-on treatments for chronic rhinosinusitus with nasal polyps (CRSwNP). This cross-sectional, retrospective, real-world study aimed to characterize treatment patterns and identify predictors of biologic use among patients with CRSwNP. METHODS: Adults in the Merative MarketScan Commercial and Medicare Supplemental Databases with medical claims for CRSwNP were identified June 2018-June 2019 (identification period [IP])...
December 8, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38053199/successful-use-of-dupilumab-for-egg-induced-eosinophilic-gastroenteritis-with-duodenal-ulcer-a-pediatric-case-report-and-review-of-literature
#36
JOURNAL ARTICLE
Mitsuru Tsuge, Kenji Shigehara, Kazuhiro Uda, Seiji Kawano, Masaya Iwamuro, Yukie Saito, Masato Yashiro, Masanori Ikeda, Hirokazu Tsukahara
BACKGROUND: Non-esophageal eosinophilic gastrointestinal disorder (non-EoE-EGID) is a rare disease in which eosinophils infiltrate parts of the gastrointestinal tract other than the esophagus; however, the number of patients with non-EoE-EGID has been increasing in recent years. Owing to its chronic course with repeated relapses, it can lead to developmental delays due to malnutrition, especially in pediatric patients. No established treatment exists for non-EoE-EGID, necessitating long-term systemic corticosteroid administration...
December 5, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38037176/diagnostic-validity-of-specific-immunoglobulin-e-levels-to-alpha-gal-in-alpha-gal-syndrome-a-cross-sectional-analysis
#37
JOURNAL ARTICLE
Adrián Germán-Sánchez, Ana Alonso-Llamazares, Fernando García-González, Bakai Matala-Ahmed, Ceny Solani Melgar-Reyes, Ignacio Antepara-Ercoreca
BACKGROUND: The diagnosis of Alpha-gal Syndrome (AGS) is based on the presence of symptoms after being exposed to potential sources of alpha-gal together with values ​​of specific IgE (sIgE) to alpha-gal ≥ 0.1 kUA/L or ≥ 0.35 kUA/L. The aim of this study was to evaluate the diagnostic validity of sIgE levels to alpha-gal ≥ 0.1 kUA/L for identifying AGS. METHODS: This was a cross-sectional analysis of adult patients with available data on sIgE levels to alpha-gal, classified into two groups according to the presence (Group 1) or absence (Group 2) of symptoms after being exposed to potential sources of alpha-gal...
November 30, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38031090/presence-of-variable-extrathoracic-airflow-limitation-in-patients-with-a-negative%C3%A2-methacholine-challenge-test
#38
JOURNAL ARTICLE
Zane Z Elfessi, Sarah Zavala, Israel Rubinstein
PURPOSE: Determine whether variable extrathoracic airflow limitation (VEAL) is observed in patients with negative methacholine challenge tests (MCT). METHODS: Electronic medical records of patients undergoing MCT at Jesse Brown VA Medical Center between January 2017 and December 2019 were reviewed. Only patients with negative MCT were selected. Pertinent demographic, clinical, and pulmonary function tests (PFT) and MCT data were abstracted from each record. Spirometric flow-volume loops recorded during each test were inspected by one co-author to determine the first inhaled methacholine concentration at which FEF50 /FIF50 was either > 1 or further increased if baseline FEF50 /FIF50 after nebulized saline (vehicle) already exceeded 1...
November 29, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38031081/infantile-atopic-dermatitis-and-maternal-infant-bonding-a-mixed-methods-study
#39
JOURNAL ARTICLE
Ayel Luis R Batac, Kaitlyn A Merrill, Michael A Golding, Manvir Bhamra, Zoe Harbottle, Isac Kopsch, Erik Wilking, Marina Jonsson, Sandra Ekström, Elissa M Abrams, Michelle A Halbrich, Elinor Simons, Leslie E Roos, Jill A Keddy-Grant, Thomas V Gerstner, Jo-Anne St-Vincent, Jennifer L P Protudjer
BACKGROUND: Childhood atopic dermatitis can have a negative effect on caregivers' quality of life and stress levels due to the burdensome nature of its treatment. Given that the condition often emerges in infancy, atopic dermatitis-related stress also carries the potential to negatively affect the developing mother-infant bond. While it is plausible that atopic dermatitis has a negative impact on maternal-infant bonding, these relationships have not been studied directly. In light of this gap, the current study investigated the association between infantile atopic dermatitis and the maternal-infant bond using a mixed-method design...
November 29, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38012745/human-placental-extract-suppresses-mast-cell-activation-and-induces-mast-cell-apoptosis
#40
JOURNAL ARTICLE
Tongqian Wu, Jingjing He, Shirong Yan, Jing Li, Ke Chen, Dingshan Zhang, Mingliang Cheng, Zou Xiang, Yu Fang
BACKGROUND: Human placental extract (HPE) has been documented to facilitate the healing of certain disorders including allergy. However, the effects of HPE on the functionality of mast cells, a critical cell type in allergic diseases, have not been reported. METHODS: To investigate the effects of HPE on the regulation of allergy with respect to the biological functions of mast cells, the mast cell line C57 or HMC-1 cells were treated with HPE followed by the assessment of cell proliferation, apoptosis, activation, chemotaxis and phagocytosis...
November 27, 2023: Allergy, Asthma, and Clinical Immunology
journal
journal
41022
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.